2019
DOI: 10.3390/molecules24173058
|View full text |Cite
|
Sign up to set email alerts
|

Cubic Liquid Crystalline Nanostructures Involving Catalase and Curcumin: BioSAXS Study and Catalase Peroxidatic Function after Cubosomal Nanoparticle Treatment of Differentiated SH-SY5Y Cells

Abstract: The development of nanomedicines for the treatment of neurodegenerative disorders demands innovative nanoarchitectures for combined loading of multiple neuroprotective compounds. We report dual-drug loaded monoolein-based liquid crystalline architectures designed for the encapsulation of a therapeutic protein and a small molecule antioxidant. Catalase (CAT) is chosen as a metalloprotein, which provides enzymatic defense against oxidative stress caused by reactive oxygen species (ROS) such as hydrogen peroxide … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
50
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 60 publications
(51 citation statements)
references
References 73 publications
1
50
0
Order By: Relevance
“…Nanoparticles and nanoassemblies may offer innovative combinations of multiple bioactive molecules to target the various mechanisms of multiple neurodegenerative diseases ( Angelova et al, 2011 , 2019b ; Fonseca-Santos et al, 2015 ; Angelova and Angelov, 2017 ; Harilal et al, 2019 ). In recent works, we have exploited self-assembly-based nanotechnologies for combination delivery of a key neurotrophic protein [brain-derived neurotrophic factor (BDNF)], curcumin, and omega-3 polyunsaturated fatty acids (ω-3 PUFAs) in order to trigger and promote neuro-repair ( Guerzoni et al, 2017 ; Angelova et al, 2018 ; Rakotoarisoa et al, 2019 ). Biomedical studies have emphasized that AD patients lose up to 60% of plasmalogens from the brain cell membranes ( Farooqui et al, 1997 ; Su et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Nanoparticles and nanoassemblies may offer innovative combinations of multiple bioactive molecules to target the various mechanisms of multiple neurodegenerative diseases ( Angelova et al, 2011 , 2019b ; Fonseca-Santos et al, 2015 ; Angelova and Angelov, 2017 ; Harilal et al, 2019 ). In recent works, we have exploited self-assembly-based nanotechnologies for combination delivery of a key neurotrophic protein [brain-derived neurotrophic factor (BDNF)], curcumin, and omega-3 polyunsaturated fatty acids (ω-3 PUFAs) in order to trigger and promote neuro-repair ( Guerzoni et al, 2017 ; Angelova et al, 2018 ; Rakotoarisoa et al, 2019 ). Biomedical studies have emphasized that AD patients lose up to 60% of plasmalogens from the brain cell membranes ( Farooqui et al, 1997 ; Su et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Even though the bioavailability of curcumin is restricted by the blood–brain barrier, many researchers had reported its highly effective therapeutic ability in the brain disorders including Alzheimer’s, Parkinson’s, and Huntington’s diseases; multiple sclerosis; depression; and schizophrenia [ 28 , 29 , 30 , 31 ]. With advancement in the field of researcher, the bioavailability of curcumin has been improved tremendously through the development of nano-particle-encapsulated curcumin administration [ 32 , 33 , 34 , 35 ]. In addition, its oral administration has been found to improve the learning and memory in animal models [ 36 , 37 , 38 , 39 , 40 , 41 ].…”
Section: Introductionmentioning
confidence: 99%
“…Curcumin (diferuloylmethane; CUR) is an active compound, extracted from rhizomes by Curcuma Longa , which has shown excellent therapeutic properties for the treatment of various diseases [ 1 , 2 , 3 , 4 , 5 ]. CUR is an excellent antioxidant that is able to prevent or slow down damage to cells caused by free radicals, as well as reactive oxygen species (ROS) and reactive nitrogen species (RNS) [ 6 ].…”
Section: Introductionmentioning
confidence: 99%